Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields

References

1. 1.↵
   2. Río J,
   3. Castilló J,
   4. Rovira A, et al

   . Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler 2009;15:848–53 doi:10.1177/1352458509104591 pmid:19542263

   Abstract/FREE Full Text
2. 2.↵
   2. Sormani MP,
   3. De Stefano N

   . Defining and scoring response to IFN-β in multiple sclerosis. Nat Rev Neurol 2013;9:504–12 doi:10.1038/nrneurol.2013.146 pmid:23897407

   CrossRefPubMed
3. 3.↵
   2. Sormani MP,
   3. Río J,
   4. Tintorè M, et al

   . Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler 2013;19:605–12 doi:10.1177/1352458512460605 pmid:23012253

   Abstract/FREE Full Text
4. 4.↵
   2. Prosperini L,
   3. Mancinelli CR,
   4. De Giglio L, et al

   . Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis. Mult Scler 2014;20:566–76 doi:10.1177/1352458513502399 pmid:23999607

   Abstract/FREE Full Text
5. 5.↵
   2. Freedman MS,
   3. Selchen D,
   4. Arnold DL, et al

   ; Canadian Multiple Sclerosis Working Group. Treatment optimization in MS: Canadian MS Working Group updated recommendations. Can J Neurol Sci 2013;40:307–23 doi:10.1017/S0317167100014244 pmid:23603165

   CrossRefPubMed
6. 6.↵
   2. Stangel M,
   3. Penner IK,
   4. Kallmann BA, et al

   . Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model. Ther Adv Neurol Disord 2015;8:3–13 doi:10.1177/1756285614560733 pmid:25584069

   Abstract/FREE Full Text
7. 7.↵
   2. Altay EE,
   3. Fisher E,
   4. Jones SE, et al

   . Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic. JAMA Neurol 2013;70:338–44 doi:10.1001/2013.jamaneurol.211 pmid:23599930

   CrossRefPubMed
8. 8.↵
   2. Moraal B,
   3. Wattjes MP,
   4. Geurts JJ, et al

   . Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology 2010;255:154–63 doi:10.1148/radiol.09090814 pmid:20308453

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Moraal B,
   3. van den Elskamp IJ,
   4. Knol DL, et al

   . Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Ann Neurol 2010;67:667–75 doi:10.1002/ana.21958 pmid:20437564

   CrossRefPubMed
10. 10.↵
    2. Lladó X,
    3. Ganiler O,
    4. Oliver A, et al

    . Automated detection of multiple sclerosis lesions in serial brain MRI. Neuroradiology 2012;54:787–807 doi:10.1007/s00234-011-0992-6 pmid:22179659

    CrossRefPubMed
11. 11.↵
    2. Battaglini M,
    3. Rossi F,
    4. Grove RA, et al

    . Automated identification of brain new lesions in multiple sclerosis using subtraction images. J Magn Reson Imaging 2014;39:1543–49 pmid:24987754

    CrossRefPubMed
12. 12.↵
    2. Elliott C,
    3. Arnold DL,
    4. Collins DL, et al

    . Temporally consistent probabilistic detection of new multiple sclerosis lesions in brain MRI. IEEE Trans Med Imaging 2013;32:1490–503 doi:10.1109/TMI.2013.2258403 pmid:23613032

    CrossRefPubMed
13. 13.↵
    2. Sweeney EM,
    3. Shinohara RT,
    4. Shea CD, et al

    . Automatic lesion incidence estimation and detection in multiple sclerosis using multisequence longitudinal MRI. AJNR Am J Neuroradiol 2013;34:68–73 doi:10.3174/ajnr.A3172 pmid:22766673

    Abstract/FREE Full Text
14. 14.↵
    2. Rey D,
    3. Subsol G,
    4. Delingette H, et al

    . Automatic detection and segmentation of evolving processes in 3D medical images: application to multiple sclerosis. Med Image Anal 2002;6:163–79 doi:10.1016/S1361-8415(02)00056-7 pmid:12045002

    CrossRefPubMed
15. 15.↵
    2. Thirion JP,
    3. Calmon G

    . Deformation analysis to detect and quantify active lesions in three-dimensional medical image sequences. IEEE Trans Med Imaging 1999;18:429–41 doi:10.1109/42.774170 pmid:10416804

    CrossRefPubMed
16. 16.↵
    2. Vrenken H,
    3. Jenkinson M,
    4. Horsfield MA, et al

    ; MAGNIMS Study Group. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol 2013;260:2458–71 doi:10.1007/s00415-012-6762-5 pmid:23263472

    CrossRefPubMed
17. 17.↵
    2. Lublin FD,
    3. Reingold SC,
    4. Cohen JA, et al

    . Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 2014;83:278–86 doi:10.1212/WNL.0000000000000560 pmid:24871874

    CrossRefPubMed
18. 18.↵
    2. Polman CH,
    3. Reingold SC,
    4. Banwell B, et al

    . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Tustison NJ,
    3. Avants BB,
    4. Cook PA, et al

    . N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 2010;29:1310–20 doi:10.1109/TMI.2010.2046908 pmid:20378467

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Ganiler O,
    3. Oliver A,
    4. Diez Y, et al

    . A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies. Neuroradiology 2014;56:363–74 doi:10.1007/s00234-014-1343-1 pmid:24590302

    CrossRefPubMed
21. 21.↵
    2. Diez Y,
    3. Oliver A,
    4. Cabezas M, et al

    . Intensity based methods for brain MRI longitudinal registration: a study in multiple sclerosis patients. Neuroinformatics 2014;12:365–79 doi:10.1007/s12021-013-9216-z pmid:24338728

    CrossRefPubMed
22. 22.↵
    2. Thirion JP

    . Image matching as a diffusion process: an analogy with Maxwell's demons. Med Image Anal 1998;2:243–60 doi:10.1016/S1361-8415(98)80022-4 pmid:9873902

    CrossRefPubMed
23. 23.↵
    2. Cabezas M,
    3. Oliver A,
    4. Roura E, et al

    . Automatic multiple sclerosis lesion detection in brain MRI by FLAIR thresholding. Comput Methods Programs Biomed 2014;115:147–61 doi:10.1016/j.cmpb.2014.04.006 pmid:24813718

    CrossRefPubMed
24. 24.↵
    2. Styner M,
    3. Lee J,
    4. Chin B, et al

    . 3D segmentation in the clinic: a grand challenge II: MS lesion segmentation. MIDAS J 2008;1–6
25. 25.↵
    2. Menke J,
    3. Martinez TR

    . Using permutations instead of Student's t distribution for p-values in paired-difference algorithm comparisons. In: Proceedings of the 2004 IEEE International Joint Conference of Neural Networks, Budapest, Hungary. July 25–29, 2004
26. 26.↵
    2. Dancey C,
    3. Reidy J

    . Statistics without Maths for Psychology: Using SPSS for Windows. New York: Prentice Hall; 2004
27. 27.↵
    2. Tintore M,
    3. Rovira À,
    4. Río J, et al

    . Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 2015;138(pt 7):1863–74 doi:10.1093/brain/awv105 pmid:25902415

    Abstract/FREE Full Text